Clinical Trials Browser

Nasopharyngeal Carcinoma

NCT06327139 2024-03-25

OPEN

Phase 3 Unknown

201 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05893810 2024-02-08

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Phase 3 Unknown

176 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00957086 2024-01-09

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

Phase 3 Unknown

710 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00415233 2023-12-19

HiLo

Phase 3 Unknown

438 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Adenocarcinoma, Follicular

NCT04964284 2023-10-23

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

Phase 3 Unknown

328 enrolled

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03700905 2023-05-23

IMSTAR-HN

Phase 3 Unknown

276 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03321539 2023-05-22

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Phase 3 Unknown

216 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03048877 2023-04-12

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Phase 3 Unknown

118 enrolled

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03700476 2023-03-28

CONTINUUM

Phase 3 Unknown

425 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT05757479 2023-03-07

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

Phase 3 Unknown

168 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05751512 2023-03-02

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Phase 3 Unknown

180 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04436965 2023-01-31

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Phase 3 Unknown

266 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Phase 3 Unknown

384 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT05519956 2022-09-19

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Phase 3 Unknown

398 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03707509 2022-07-01

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

263 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

Phase 3 Unknown

640 enrolled

Head & Neck

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Phase 3 Unknown

420 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02512315 2021-08-30

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

Phase 3 Unknown

192 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02661152 2021-04-13

DAHANCA30

Phase 3 Unknown

1,252 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Phase 3 Unknown

208 enrolled

Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

NCT04780750 2021-03-03

Concurent Chemoradiotherapy in Head and Neck Cancers

Phase 3 Unknown

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04766359 2021-02-23

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

Phase 3 Unknown

364 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Phase 3 Unknown

590 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03720340 2020-08-11

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Phase 3 Unknown

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04502641 2020-08-06

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

Phase 3 Unknown

160 enrolled

Head & Neck

Hypopharyngeal Neoplasms

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

562 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04061278 2020-05-12

A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

Phase 3 Unknown

246 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02111460 2020-05-08

Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

126 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04146402 2020-02-05

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Phase 3 Unknown

330 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03855384 2019-10-30

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Phase 3 Unknown

334 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03403829 2019-07-08

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Phase 3 Unknown

360 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02958111 2019-06-12

CAN

Phase 3 Unknown

406 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03601975 2019-02-04

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

336 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02633202 2018-12-13

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Phase 3 Unknown

338 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03685409 2018-09-26

Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions

Phase 3 Unknown

62 enrolled

Head & Neck

Mouth Neoplasms

NCT03656965 2018-09-04

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Phase 3 Unknown

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02434614 2018-05-16

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

440 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

480 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00115895 2018-03-02

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

Phase 3 Unknown

160 enrolled

Head & Neck

Thyroid Neoplasms

NCT00999700 2017-09-05

INTERCEPTOR

Phase 3 Unknown

282 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01874171 2017-05-08

De-ESCALaTE

Phase 3 Unknown

334 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03068936 2017-03-03

IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

Phase 3 Unknown

716 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03015727 2017-01-10

IRCNPC

Phase 3 Unknown

440 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02944708 2016-10-27

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

384 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02048254 2016-06-13

Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer

Phase 3 Unknown

90 enrolled

Head & Neck

Salivary Gland Neoplasms

NCT02786641 2016-06-01

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

235 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01212354 2016-02-09

Escalox

Phase 3 Unknown

270 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

OPEN

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

HiLo

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

IMSTAR-HN

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

CONTINUUM

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

AF CRT +/- Nimorazole in HNSCC

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

DAHANCA30

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Concurent Chemoradiotherapy in Head and Neck Cancers

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

CAN

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

INTERCEPTOR

De-ESCALaTE

IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

IRCNPC

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Escalox

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma